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Abstract
Introduction: Pregnancy has been linked to increased rates of arteriovenous malformation rupture. This link
remains a matter of debate and very few studies have addressed the management of arteriovenous malformation
in pregnancy. Unruptured arteriovenous malformations in pregnant woman generally warrant conservative
management due to the low rupture risk. When pregnant women present with ruptured arteriovenous
malformation, however, surgery is often indicated due to the increased risk of re-rupture and associated mortality.
Endovascular embolization is widely accepted as an important component of contemporary, multimodal therapy
for arteriovenous malformations. Although rarely curative, embolization can facilitate subsequent surgical resection
or radiosurgery. No previous reports have been devoted to the endovascular management of an arteriovenous
malformation in a pregnant woman.
Case presentation: A 23-year-old Caucasian woman presented with headache and visual disturbance after the
rupture of a left parieto-occipital arteriovenous malformation in the 22nd week of her pregnancy. After involving
high-risk obstetric consultants and taking precautions to shield the fetus from ionizing radiation, we proceeded
with a single stage of endovascular embolization followed soon after by open surgical resection of the
arteriovenous malformation. There were several goals for the angiography in this patient: to better understand the
anatomy of the arteriovenous malformation, including the number and orientation of feeding arteries and draining
veins; to look for associated pre-nidal or intra-nidal aneurysms; and to partially embolize the arteriovenous
malformation via safely-accessible feeders to facilitate surgical resection and minimize blood loss and operative
morbidity.
Conclusion: From our experience and review of the literature, we maintain that ruptured arteriovenous
malformations in pregnancy may be managed in a similar manner to those in non-gravid women. Precautions
should be taken to reduce the operative time and exposure of the fetus to ionizing radiation and contrast agents.
Introduction
The rupture of an intracranial arteriovenous malforma-
tion (AVM) in pregnancy is a rare occurrence, but may
have fatal consequences [1]. A link between AVM rup-
ture and pregnancy has been proposed; it may be caused
by the increased cardiac output or circulatory effects of
the elevated estrogen levels [2]. However, in some series
the reported hemorrhage rate from AVMs in pregnancy
is around 0.6% to 3.5%, which is similar to the 2% to 4%
rate in non-pregnant women. Due to this low risk of
hemorrhage, most authors recommend conservative
management of unruptured AVMs during pregnancy
[2,3]. An aggressive approach is warranted, however,
when pregnant patients present with a ruptured AVM.
The risk of re-bleed during the same pregnancy (27% to
30%) is greater than the risk of re-bleed in non-gravid
women within one year of their initial bleed (6%). These
bleeds in pregnant women are associated with high
maternal and fetal mortality (10% to 40%) [2,4]. Thus,
despite the potentially deleterious effects of radiation on
the fetus, surgical management is generally indicated
when pregnant women present with a ruptured AVM. * Correspondence: walter.j.jermakowicz@vanderbilt.edu
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been managed surgically with great success [2,3,5]. In
patients presenting with AVM rupture, resection has been
shown to be associated with lower rates of maternal and
fetal mortality when compared to conservative manage-
ment [4,6]. More recently, with advances in endovascular
technology, embolization of AVMs has been used as an
adjuvant to surgery, if not as a primary mode of treatment,
with much success. However, the role of endovascular
embolization in the management of AVM rupture in preg-
nant women has not been established.
Here, we report the case of a 22-week-pregnant woman
who presented with a symptomatic ruptured AVM, trea-
ted with embolization followed by surgical resection.
There were several goals for the angiography in this
patient: to better understand the anatomy of the AVM,
including the number and orientation of feeding arteries
and draining veins; to look for associated pre-nidal or
intra-nidal aneurysms; and to partially embolize the
AVM via safely-accessible feeders to facilitate surgical
resection and minimize blood loss and operative
morbidity.
Case presentation
A 23-year-old Caucasian woman, 22 weeks into her first
pregnancy, presented to an outside hospital following the
sudden onset of severe headache associated with nausea
and vomiting. She denied weakness or numbness, but
reported occasional double vision. Her past medical
history was significant for an irregular heartbeat, gastroe-
sophageal reflux disease and hypertension. Our patient’s
only physical exam finding was a right lower visual field
deficit but otherwise she was intact. Non-contrasted com-
puted tomography of her head revealed an acute left par-
ieto-occipital hemorrhage with mild mass effect. Magnetic
resonance imaging (MRI) revealed a 5 × 2.6 cm hematoma
in the left parieto-occipital region abutting the ventricle
with flow voids, characteristic of an AVM (Figure 1). Mild
mass effect was noted with no midline shift or effacement
of basilar cisterns. Digital subtraction cerebral angiography
demonstrated that the nidus was being supplied by the
posterior branches of her left middle cerebral, left anterior
and posterior cerebral arteries. The majority of the venous
drainage was via her superior sagittal sinus. No intra-nidal
or flow-related aneurysms were noted. Our patient was
counseled with regards to her options and opted for endo-
vascular embolization followed by surgical resection of the
AVM.
Our patient was brought to the endovascular suite three
weeks after her initial hemorrhage. The procedure was
coordinated with obstetricians as well as anesthesiologists
to ensure the safety of both the mother and fetus. During
the procedure, various measures were taken to minimize
exposure of the fetus to ionizing radiation. Our patient’s
abdomen was fully covered with lead drapes. In addition,
instead of performing a full angiogram prior to the embo-
lization, we used a prior MRI scan to determine the pri-
mary pedicle with the greatest promise of having nidal
feeders and then selectively targeted that vessel during the
embolization procedure. The guide catheter was posi-
tioned in her distal left internal carotid artery. A micro-
catheter was navigated over a guidewire to select the
inferior division of the middle cerebral artery feeding the
AVM. Visipaque™ 320 (iodixanol) contrast agent was
used at half strength. After ensuring the selected branch
was feeding the nidus, Onyx-18 (Onyx Liquid Embolic
System
®) was used in the standard fashion [7-9] to embo-
lize the AVM. Control runs after embolization revealed
the successful reduction of the nidus by approximately
50%, preserving venous outflow (Figure 2). After the pro-
cedure, our patient was transferred to the neurosurgical
intensive care unit for close observation. She had an
uncomplicated postoperative course.
Three weeks later, our patient was brought to the neu-
rosurgical operating suite and anesthetized by obstetric
anesthesia. The obstetrics team was also in the room and
was monitoring the fetus during the entire procedure.
After insertion of a right femoral sheath in the standard
fashion, our patient was put in the prone position for the
craniotomy. Stealth guidance was used to plan our cra-
niotomy prior to incision. The craniotomy was centered
over the left parieto-occipital AVM and using the stan-
dard microsurgical technique we proceeded to safely and
effectively resect the AVM. Once we were satisfied with
our resection we performed an intraoperative cerebral
angiogram. Once again, all possible measures were taken
to reduce radiation and contrast exposure to mother and
fetus. The angiogram revealed complete resection of the
AVM. The wound was closed in the standard fashion and
our patient was transferred to the neurosurgical intensive
care unit.
Figure 1 Magnetic resonance imaging of the left parieto-
occipital arteriovenous malformation. T2-weighted magnetic
resonance imaging scans of the malformation and associated
hematoma from the outside hospital showing (A) axial and (B)
sagittal views.
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was discharged home on postoperative day two. At the
time of this submission, our patient had delivered her
baby at 39 weeks via a normal vaginal delivery at an
outside hospital without the need for high-risk obstetric
personnel. Both mother and baby are healthy and with
no complications related to the procedures.
Discussion
Given the increased risk of re-hemorrhage in pregnant
mothers that present with AVM bleed and the high
associated maternal and fetal mortality [2,6,10],
aggressive management of these lesions during preg-
nancy is warranted. These patients should be treated
similarly to their non-gravid counterparts. There are
also several additional risk factors that increase the like-
lihood of AVM hemorrhage and may be considered
when indications for surgery are not clear. These
include hypertension, increased age, coagulopathy, disse-
minated intravascular coagulation and recent use of
vasoactive substances [11]. Of these risk factors, our
patient had untreated gestational hypertension, which is
the single factor most closely linked with AVM rupture
[11].
Figure 2 Sagittal angiography comparing the vasculature after injection of the contrast agent through the left middle cerebral pedicle,
before and after endovascular embolization. (A and D) show the early arterial phase. (B and E) show the late arterial phase. The black arrow in B
shows the arteriovenous malformation nidus. (C and F) show images during the capillary phase. The large tortuous draining vein is clearly visible in
place of the arteriovenous malformation nidus. We estimated a 50% reduction in arteriovenous malformation size after embolization.
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ing frequency for the treatment of AVMs in the general
population. Embolization may either be performed as
stand-alone treatment or as part of a multimodal therapy.
When embolization is used alone for the definitive treat-
ment of AVMs, the reported cure rates are 5% to 28%,
lower than the cure rates of surgical resection (80% to
95%) and radiosurgery (65% to 85%). In addition, stand-
alone embolic therapy has relatively high morbidity (4%
to 9%) and mortality (2% to 4%) when compared to surgi-
cal resection and radiosurgery. These complications are
due, largely, to the fact that the more complicated AVMs
tend to be the ones that receive endovascular treatment
[7,9,12]. The utility of endovascular embolization, how-
ever, becomes more apparent when used prior to surgical
resection. In such cases the embolization typically
r e d u c e st h es i z eo ft h eA V Ma n dm a yi m p r o v es a f e t y
during the subsequent resection. For instance, it is
thought that reducing the AVM in a step-wise fashion
with embolization lowers the risks for normal perfusion
pressure break-through syndrome, where a diversion of
the AVM’s blood towards other vessels leads to cerebral
edema and hemorrhage [8]. Also, because embolization
during multimodal therapy is less aggressive than during
stand-alone therapy, the morbidity (4% to 6%) and mor-
tality (0% to 2%) tend to be lower [8,13,14]. There is a
lack of studies that compare cure rates and complications
of endovascular embolization with surgery versus surgery
alone. In a retrospective study, Deruty et al. [15] had an
82% cure rate in 19 patients managed with surgery alone
and a 100% cure rate in 19 patients managed with both
embolization and surgery, suggesting a benefit to emboli-
zation before surgery.
For small AVMs or lesions in easily accessible areas, sur-
gery alone may be suitable. However, when lesions are
large, in deep areas or have many feeders, embolization
before surgery may increase the cure rate while reducing
the overall risk. When these procedures are performed in
pregnant women, proper shielding of the abdomen and
minimizing the use of ionizing radiation are of particular
importance. The use of selective angiography, for example,
minimizes fluoroscopy time and radiation exposure.
Visipaque™ is not contraindicated in pregnancy; however,
use of half strength contrast may further increase safety.
In addition, while Onyx
® embolization was effective in
this case, an argument could be put forth for using
N-butyl 2-cyanoacrylate, for which the actual embolization
process is considerably quicker. The involvement of a
high-risk obstetric team with fetal heart monitoring cap-
ability also provides valuable protection. Experience with
intravascular procedures in pregnant women will further
help guide management of this rare, but important patient
population.
Conclusions
The rupture of an AVM in a pregnant patient is a ser-
ious complication that requires surgical intervention.
The use of endovascular embolization with surgical
resection is safe in these patients, particularly when
measures are taken to protect the fetus, and may pro-
vide benefits over the use of surgery or embolization
alone.
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